FibroGen Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $17.48 million.
The company employs approximately 599 people and operates in the Services sector, within the Commercial Services industry.
Over the past 12 months, FibroGen Inc. reported $-118.09 million in revenue, generating net income of $215.66 million.
Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker FGEN.